Don't Cry For Me Avita

I'm relatively new to small cap stocks but the more I read about AVH the more there is to like about this biotech stock.
What I didn't realize until reading the last company investor presentation was just how rapidly skin autografts can be made and for such a diverse range of conditions. Some of the pictorial diaries of treatment in the latest company presentation are compelling.
The device looks incredibly portable.
Apparently it is easy to operate.
With little or no risk.

The US military are interested in the device.

Sinopharm, China's largest healthcare group recently agreed to distribute the product.

So why is the share price flat? Are we waiting until the next quarterly report to see whether the great marketing and distribution deals convert into dollars?

Comment?